Who are O6-benzylguanine's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/o6-benzylguanine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

O6-benzylguanine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

O6-benzylguanine (O6-benzylguanine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: DNA repair inhibitor / Alkyltransferase inhibitor. Area: Oncology.

phase 3 DNA repair inhibitor / Alkyltransferase inhibitor O6-alkylguanine-DNA alkyltransferase (AGT) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

O6-benzylguanine (O6-benzylguanine) — Case Comprehensive Cancer Center. O6-benzylguanine is an alkyltransferase inhibitor that depletes the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), sensitizing cancer cells to alkylating chemotherapy agents.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
O6-benzylguanine TARGET	O6-benzylguanine	Case Comprehensive Cancer Center	phase 3	DNA repair inhibitor / Alkyltransferase inhibitor	O6-alkylguanine-DNA alkyltransferase (AGT)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (DNA repair inhibitor / Alkyltransferase inhibitor class)

Case Comprehensive Cancer Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). O6-benzylguanine — Competitive Intelligence Brief. https://druglandscape.com/ci/o6-benzylguanine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab